OnabotulinumtoxinA in the treatment of refractory chronic cluster headache

BACKGROUND: Cluster headache (CH) is a clinically well-defined primary headache disorder, approximately 20% of cluster headache sufferers experience recurrent attacks without periods of significant remission. For the treatment of chronic cluster headache (CCH) only limited therapeutic options are av...

Descripción completa

Detalles Bibliográficos
Autores principales: Lampl, Christian, Rudolph, Mirjam, Bräutigam, Elisabeth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6006000/
https://www.ncbi.nlm.nih.gov/pubmed/29915913
http://dx.doi.org/10.1186/s10194-018-0874-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6006000/
https://www.ncbi.nlm.nih.gov/pubmed/29915913
http://dx.doi.org/10.1186/s10194-018-0874-y

Ejemplares similares